Burcon Awarded Third U.S. CLARISOY Patent in Two Months

Burcon Awarded Third U.S. CLARISOY Patent in Two Months

VANCOUVER, British Columbia, April 11, 2013 (GLOBE NEWSWIRE) -- Burcon
NutraScience Corporation (TSX:BU) (Nasdaq:BUR), a leader in functional,
renewable plant proteins, has been awarded U.S. patent No. 8,409,654 for a
process used to produce CLARISOY ™ soy protein.

The award marks the third U.S. patent received by Burcon within the last two
months for processes used to produce CLARISOY soy protein, and it supports
CLARISOY as the first plant-based protein extraction technology able to
deliver high-quality nutrition in low pH beverages, like sports drinks and
juices, along with unmatched transparency, solubility and clean taste.

"Our patent strategy for CLARISOY since day-one has been to protect our
valuable intellectual property through a comprehensive patent structure," said
Johann F. Tergesen, Burcon's president and COO. "Burcon's major asset is our
intellectual property, as demonstrated by the license agreement we signed with
Archer Daniels Midland Company for the worldwide production, distribution and
sale of CLARISOY soy protein."

Burcon's intellectual property strategy for CLARISOY focuses on protecting the
commercial opportunity of having the world's first plant-based protein capable
of offering both clarity and high-quality protein nutrition in low pH
beverages. "CLARISOY's unique functional and nutritional attributes are what
drive its strong commercial value," noted Tergesen.

To protect this commercial value, Burcon has filed numerous patent
applications along three patent categories:

Process:covering technologies for protein extraction and purification.

Use: covering various commercial applications, e.g., CLARISOY as a functional
nutrient in sports drinks.

Composition of matter: covering the "signature characteristics" of its
products, e.g., the specific measure of CLARISOY solubility at various pH
ranges.

In addition to U.S. patent applications, Burcon has applied for international
protections of its intellectual property in some 35 countries under the Patent
Cooperation Treaty of the World Intellectual Property Organization, including
in the European Union, Japan, China, India, Australia, New Zealand and
Canada.

Burcon's patent portfolio now consists of 225 issued patents in various
countries,including 39 in the U.S., as well as more than 400 active patent
applications,including 80 additional U.S. patent applications.

About CLARISOY Soy Protein

CLARISOY soy protein is the world's first plant-based protein capable of
offering both clarity and high-quality protein nutrition in low pH beverage
systems.CLARISOY is under exclusive license to Archer Daniels Midland
Company (ADM), which offers a range of products for both low and neutral pH
applications, allowing food and beverage companies to easily include up to 10
grams of CLARISOY per 500mL serving.

ADM's CLARISOY-based products include CLARISOY 100, a premier vegetable-based
protein that offers both clarity and high-quality protein nutrition for
beverages with a pH of less than four. Extremely heat stable, CLARISOY 100
requires no homogenization or stabilizers in low pH beverages. It is
specifically designed to enable beverage manufacturers to meet the demand for
great-tasting, nutritionally enhanced beverages by the growing number of
health and wellness oriented consumers. Applications include sport nutrition
beverages, citrus-based drinks, fruit-flavored beverages, fruit-juice blends,
lemonades, powdered beverage mixes and fortified waters.

CLARISOY 150 is a revolutionary soy protein for neutral pH beverages and low
pH beverages with cloud systems. The clean flavor and smooth mouth-feel makes
CLARISOY 150 a formulator's ideal protein ingredient.

For more information about CLARISOY, go towww.clarisoy.com

About Burcon NutraScience Corporation

Burcon NutraScience is a leader in nutrition, health and wellness in the field
of functional plant proteins. The company has developed a portfolio of
composition, application, and process patents originating from a core protein
extraction and purification technology.Burcon has developed: CLARISOY™ soy
protein - now licensed to Archer Daniels Midland Company - which offers
clarity and high-quality protein nutrition for low pH beverage systems and
exceptionally clean flavor at any pH; Peazazz™ a uniquely soluble and
clean-tasting pea protein; and Puratein®, Supertein™ and Nutratein™ are canola
protein isolates with unique functional and nutritional attributes. For more
information about the company, visitwww.burcon.ca

ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
President and Chief Operating Officer

The TSX has not reviewed and does not accept responsibility for the adequacy
of the content of the information contained herein. This press release
contains forward-looking statements or forward-looking information.
Forward-looking statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results, performances,
prospects and opportunities to differ materially from those expressed or
implied by such forward-looking statements. All statements other than
statements of historical fact included in this release are forward-looking
statements, including, without limitation, statements regarding plans and
timing for the introduction or enhancement of our products, statements about
future market conditions, supply and demand conditions, and other
expectations, intentions and plans contained in this press release. There can
be no assurance that such statements will prove to be accurate and actual
results and future events could differ materially from those anticipated in
such statements or information. Important factors that could cause actual
results to differ materially from Burcon's plans and expectations include the
actual results of marketing activities, adverse general economic, market or
business conditions, regulatory changes and other risks and factors detailed
herein and from time to time in the filings made by Burcon with securities
regulators and stock exchanges, including in the section entitled "Risk
Factors" in Burcon's annual information form dated June 25, 2012. Any
forward-looking statement or information only speaks as of the date on which
it was made and, except as may be required by applicable securities laws,
Burcon disclaims any intent or obligation to update any forward-looking
statement, whether as a result of new information, future events or otherwise.
Although Burcon believes that the assumptions inherent in the forward-looking
statements are reasonable, forward-looking statements are not guarantees of
future performance and accordingly undue reliance should not be put on such.

CONTACT: Media & Industry Contact:
         Michael Kirwan
         Director, Corporate Development
         Burcon NutraScience Corporation
         (604) 733-0896
         (888) 408-7960 toll-free
         mkirwan@burcon.ca www.burcon.ca
        
         Investor Relations Contact:
         John MacLennan
         Managing Director
         Tel (416) 644.8688
         john@liolios.com
 
Press spacebar to pause and continue. Press esc to stop.